Clinical Trial Update: R21 Roche: 3-Way Tau Tracers in AD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by Washington University and Roche is evaluating three tau tracer compounds for Alzheimer's disease; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• R21 Roche 3-Way Tau Tracer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING